The C1473G Mutation in the Mouse Tph2 Gene: From Molecular Mechanism to Biological Consequences小鼠Tph2基因中的C1473G突变:从分子机制到生物学后果BiomoleculesIF4.82025-03-210OA
On an association between fear-induced aggression and striatal-enriched protein tyrosine phosphatase (STEP) in the brain of Norway ratsBIOMEDICINE & PHARMACOTHERAPYIF7.52022-03-017OAAI
Tryptophan hydroxylase 2 deficiency modifies the effects of chronic fluoxetine treatment on the brain serotonin system and behavior in zebrafishEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Fluoxetine treatment effect on photoperiodic alterations in behavior, brain serotonin and brain-derived neurotrophic factor in tumor necrosis factor knockout miceEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Quantification of ectopic overexpression of agouti gene in the brain of mice with lethal yellow mutationEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Effect of 5-HT1A receptor gene overexpression in hippocampus on behavior and neuroplasticity in BTBR mice - animal model of autismEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72020-11-010PREAI
Effect of the 5-HT7 receptor gene overexpression on behaviour and serotonin brain system in mice with predisposition to depressive-like behaviourEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72020-11-011PREAI
Comparison of different BDNF transcripts in the brain of aggressive and tame rats. STEP inhibitor reduced the genetically-defined aggressive behaviorEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-010PREAI
Effect of C1473G polymorphism in tryptophan hydroxylase 2 and lipopolysaccharide on serotonin and protein tyrosine phosphatase 5 in mouse brainEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-010PREAI
Antidepressant-like activity of cyclo-l-prolylglycine and its possible mechanismEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-012PREAI
Effect of interaction between lethal yellow mutation in the agouti gene and zbtb33 gene knockout on mouse brain and behaviorEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-010PREAI
Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviorsNATURE COMMUNICATIONSIF15.72019-09-0277OAAI
Alterations in the expression and activity of STEP in the mouse brain induced by genetically defined obesity and lipopolysaccharide (LPS) administrationEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-011PREAI
Role of tumor necrosis factor gene in acute lipopolysacharide effect on behavior, brain expression of interleukins and brain serotonin system in miceEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI
Effects of acute and chronic treatment of STEP inhibitor, TC-2153, on the nervous system and behaviour of zebrafish (Danio rerio)EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI
Inhibitor of Striatal-Enriched Protein Tyrosine Phosphatase, 8-(Trifluoromethyl)-1,2,3,4,5-Benzopentathiepin-6-Amine hydrochloride (TC-2153), Produces Antidepressant-Like Effect and Decreases Functional Activity and Protein Level of 5-HT2A Receptor in the BrainneuroscienceIF2.82018-12-0124PREAI
Effect of brain-derived neurotrophic factor treatment on behavior and brain serotonin system in tumor necrosis factor-α knockout miceEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72017-10-010PREAI
The effect of TC-2153, an inhibitor of striatal-enriched protein tyrosine phosphatase, on the 5-HT2A receptorsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72017-10-010PREAI
Role of C1473G polymorphism in tryptophan hydroxylase-2 gene in effect of chronic fluoxetine treatment on behavior and brain serotonin systemEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72016-10-010PREAI
The transfer of the main locus of catalepsy to the genome of C57Bl/6 strain produced profound alterations in the brain morphology and behaviorEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72016-10-010PREAI